VSTM2L is a promising therapeutic target and a prognostic soluble-biomarker in cholangiocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

VSTM2L is a promising therapeutic target and a prognostic soluble-biomarker in cholangiocarcinoma

Published:2024-04-22 Issue:7 Volume:57 Page:324-329
ISSN:1976-670X
Container-title:BMB Reports
language:en
Short-container-title:BMB Rep

Author:

Lee Jungwhoi¹^ORCID,Sim Woogwang²,Lee Jungsul³,Kim Jae-Hoon¹⁴

Affiliation:

1. Department of Applied Life Science, Jeju National University, Jeju 63243, Korea

2. Department of Anatomy, University of California San Francisco, CA 94143, USA

3. Department of Bio and Brain Engineering, KAIST, Daejeon 34141, Korea

4. Subtropical/Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea

Funder

National Research Foundation of Korea

Ministry of Education

Publisher

Korean Society for Biochemistry and Molecular Biology - BMB Reports

Link

https://pdf.medrang.co.kr/BMB/2024/057/BMB057-07-03.pdf

Reference19 articles.

1. Cholangiocarcinoma

2. New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin

3. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

4. Cholangiocarcinoma: Modern advances in understanding a deadly old disease

5. Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VSTM2L protects prostate cancer cells against ferroptosis via inhibiting VDAC1 oligomerization and maintaining mitochondria homeostasis;2024-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP